Unknown

Dataset Information

0

Peptide vaccination in Montanide adjuvant induces and GM-CSF increases CXCR3 and cutaneous lymphocyte antigen expression by tumor antigen-specific CD8 T cells.


ABSTRACT: T cell infiltration of melanoma is associated with enhanced clinical efficacy and is a desirable endpoint of immunotherapeutic vaccination. Infiltration is regulated, in part, by chemokine receptors and selectin ligands on the surface of tumor-specific lymphocytes. Therefore, we investigated the expression of two homing molecules--CXCR3 and CLA - on vaccine-induced CD8 T cells, in the context of a clinical trial of a melanoma-specific peptide vaccine. Both CXCR3 and CLA have been associated with T cell infiltration of melanoma. We demonstrate that a single subcutaneous/intradermal administration of peptide vaccine in Montanide adjuvant induces tumor-specific CD8 T cells that are predominantly positive for CXCR3, with a subpopulation of CXCR3(+)CLA(+) cells. Addition of GM-CSF significantly enhances CXCR3 expression and increases the proportion of CLA-expressing cells. Concurrent with CXCR3 and CLA expression, vaccine-induced CD8 cells express high levels of Tbet, IFN-?, and IL-12R?1. Collectively, these studies demonstrate that peptide vaccination in adjuvant induces CD8 T cells with a phenotype that may support infiltration of melanoma.

SUBMITTER: Clancy-Thompson E 

PROVIDER: S-EPMC3873151 | biostudies-literature | 2013 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications

Peptide vaccination in Montanide adjuvant induces and GM-CSF increases CXCR3 and cutaneous lymphocyte antigen expression by tumor antigen-specific CD8 T cells.

Clancy-Thompson Eleanor E   King Laura K LK   Nunnley Lenora D LD   Mullins Irene M IM   Slingluff Craig L CL   Mullins David W DW  

Cancer immunology research 20131101 5


T cell infiltration of melanoma is associated with enhanced clinical efficacy and is a desirable endpoint of immunotherapeutic vaccination. Infiltration is regulated, in part, by chemokine receptors and selectin ligands on the surface of tumor-specific lymphocytes. Therefore, we investigated the expression of two homing molecules--CXCR3 and CLA - on vaccine-induced CD8 T cells, in the context of a clinical trial of a melanoma-specific peptide vaccine. Both CXCR3 and CLA have been associated with  ...[more]

Similar Datasets

| S-EPMC4019890 | biostudies-literature
2012-09-11 | GSE40743 | GEO
2012-09-11 | E-GEOD-40743 | biostudies-arrayexpress
| S-EPMC3046275 | biostudies-literature
| S-EPMC3620231 | biostudies-literature
| S-EPMC3620231 | biostudies-literature
| S-EPMC4385005 | biostudies-literature
| S-EPMC5581724 | biostudies-literature
| S-EPMC6091668 | biostudies-other
| S-EPMC7037240 | biostudies-literature